Swiss, EMA, US Pharmacopoeia and World Health Organization Authorities to Provide an Update on Cool Chain Regulations

News provided by

Pharma IQ

23 Jan, 2012, 09:59 GMT

LONDON, January 23, 2012 /PRNewswire/ --

Representatives of Swiss, EMA, US Pharmacopoeia and WHO will discuss the new regulatory landscape as well as provide the feedback from recent inspections of pharmaceutical manufacturers at 11th Annual Cool Chain Logistics Europe, 30 January - 01 February 2012 in Basel, Switzerland.

Over 400 attendees including senior representatives from : Novo Nordisk, Genzyme, Pfizer, Abbott, Pliva, Amgen, Bayer, GlaxoSmithKline, Johnson & Johnson, Ipsen, Roche, Novartis, Sanofi, Alcon Couvreur, Agilent, Allergan, Baxter, Bacher, Celgene, Biotest, Synthes, Shire Pharmaceuticals and Forest Laboratories will meet to discuss issues such as regulatory GDP guidelines, distribution partnerships and ambient transportation solutions.

For more information on the event, visit http://www.coolchaineurope.com/news, email: enquire@iqpc.co.uk or call: +44-(0)207-368 9300

Press are invited to attend this important industry forum. If you would like to a press pass, please email Joanna Checinska on joanna.checinska@iqpc.co.uk

Media contact:

Joanna Checinska
joanna.checinska@iqpc.co.uk
http://www.coolchaineurope.com